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Abstract Herp is an endoplasmic reticulum (ER)-stress-induc-
ible membrane protein, which has a ubiquitin-like domain
(ULD). However, its biological function is as yet unknown.
Previously, we reported that a high expression level of Herp
in cells increases the generation of amyloid L-protein (AL) and
that Herp interacts with presenilin (PS). Here, we addressed the
role of the ULD of Herp in AL generation and intracellular
Herp stability. We found that the ULD is not essential for
the enhancement of AL generation by Herp expression and
the interaction of Herp with PS, but is involved in the rapid
degradation of Herp, most likely via the ubiquitin/proteasome
pathway. Thus, the ULD of Herp most likely plays a role in the
regulation of the intracellular level of Herp under ER stress.
* 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
Key words: Presenilin; Herp; Amyloid L-protein;
Endoplasmic reticulum stress; Ubiquitin-like domain;
Proteasome
1. Introduction
Amyloid L-protein (AL), which is the major component of
senile plaques in the brains of patients with Alzheimer’s dis-
ease (AD), is generated from the amyloid precursor protein
(APP) through its sequential proteolytic cleavage catalyzed by
L- and Q-secretases (reviewed in [1]). L-Secretase was identi¢ed
as a membrane-tethered aspartyl protease [2] ; Q-secretase,
however, remains to be clari¢ed, although presenilin (PS)
was found to be essential for inducing Q-secretase activity
[3^6]. Mutations in the PS genes, PS1 and PS2, cause early-
onset familial AD (reviewed in [1]). PS is a multiple trans-
membrane protein and forms a high-molecular-weight com-
plex with several other proteins (reviewed in [6]). Recent stud-
ies have shown that the PS complex, including nicastrin, PEN-
2 and APH-1, is responsible for inducing Q-secretase activity
[7^10]. However, it still remains unknown how the PS-medi-
ated Q-cleavage is regulated. In order to elucidate how the
Q-cleavage is regulated, we have recently developed a new
functional screening method for identifying cDNAs that en-
hance Q-cleavage using the combination of puromycin resis-
tance assay and AL quantitation [11]. Previously, we have
identi¢ed Herp using this screening method [12]. Herp was
originally identi¢ed as a homocysteine-inducible gene and
was found to be also inducible by endoplasmic reticulum
(ER) stress [13,14]. Homocysteine or the inducers of ER
stress, including thapsigargin, induce the expression of Herp
mRNA approximately 50-fold over levels observed in un-
treated cells [13]. We have demonstrated that a high expres-
sion level of Herp, which is comparable to the level induced
by homocysteine or ER stress, increases PS-mediated AL gen-
eration, possibly through Herp binding to PS [12]. Interest-
ingly, elevated levels of homocysteine in plasma are likely to
be a risk factor for AD [15]. Therefore, Herp induced by a
high level of homocysteine may play an important role in AL
accumulation, including the formation of senile plaques or
vascular AL deposits in AD. Herp is a membrane protein
localized in the ER and it has an N-terminal ubiquitin-like
domain (ULD) [13] ; however, the precise function of this
protein and the role of the ULD of Herp have not been
established.
Ubiquitin is a highly conserved small protein widely present
in all eukaryotic cells. The modi¢cation of cellular proteins
with ubiquitin targets them for degradation by proteasome.
Accumulating evidence has shown that ubiquitin-like proteins
(ULPs), which have structural similarity to ubiquitin, are also
present in cells. ULPs are divided into two subclasses (re-
viewed in [16]): small, type-1 ULPs, such as SUMO-1 and
NEDD8, which are ligated to target proteins in a manner
analogous to the ubiquitination pathway (reviewed in [17]),
and type-2 ULPs that contain a ubiquitin-like structure in
large proteins, such as elongin B [18], Rad23 [19], parkin
[20] and Herp [13]. Although type-1 ULPs constitute a new
type of post-translational protein-modifying system, the bio-
logical signi¢cance of type-2 ULPs remains to be clari¢ed.
The ULD of elongin B appears to have a chaperone-like
function [18], whereas a recent report showed that the intra-
cellular level of parkin is regulated by the ULD [21]. In this
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study, we determined the role of the ULD of Herp. For this
purpose, we ¢rst investigated whether the ULD of Herp is
involved in the pathway leading to the enhancement of AL
generation caused by a high expression level of Herp, since the
precise mechanism underlying this action is not known. Sec-
ond, we determined whether the cellular level of Herp is regu-
lated by this domain via the ubiquitin/proteasome pathway
similar to the function of ubiquitin.
2. Materials and methods
2.1. Antibodies, reagents and cell lines
An a⁄nity-puri¢ed rabbit anti-Herp antibody was prepared as pre-
viously described [13]. A rat anti-PS1 antibody (for the N-terminal
fragment (NTF) of PS1) and a rabbit anti-PS2 antibody (for the
NTF) were purchased from Chemicon International (Temecula, CA,
USA) and Santa Cruz Biotechnology (Santa Cruz, CA, USA), respec-
tively. A monoclonal antibody 6E10 speci¢c to human AL1^17 was
purchased from Senetek (St. Louis, MO, USA). BA27 speci¢c to the
AL40 terminal site, BC05 speci¢c to the AL42 terminal site and
BNT77 raised against human AL11^28 have all been characterized
previously [22]. The 369 antibody was raised against the C-terminal
residues of APP695 [23]. A monoclonal anti-FLAG antibody and a
rabbit polyclonal anti-FLAG antibody were purchased from Sigma.
Anti-multi-ubiquitin antibody was purchased from MBL. Cyclohexi-
mide was purchased from Wako. Lactacystin was purchased from
Kyowa. Monoclonal antibody against L-tubulin was purchased from
Babco (Richmond, CA, USA). HEK293 cells stably transfected with
APP695 and PS1, which were used for the study of the interaction
between PS1 and Herp, were generated as previously reported [12].
2.2. Plasmids and retrovirus-mediated infection
pMX-Herp was generated as previously described. The vUb-Herp
cDNA encoding Herp lacking Val10 to Cys86 of Herp was inserted at
the EcoRI and SalI sites of pMX (designated pMX-vUb-Herp). We
generated C-terminally FLAG-tagged vUb-Herp using the polymer-
ase chain reaction method (sense primer: GGAATTCGCCACCATG-
GAGTCCGAGACCGA; antisense primer: GCGTCGACTCACT-
TATCGTCATCGTCCTTGTAGTCGTTTGCGATGGCTGGGGG-
GC) from Herp cDNA. This cDNA was inserted into pCI (Promega)
at EcoRI and SalI sites (designated pCI-vUb-Herp-F). The EcoRI-
SalI fragment of pCI-vUb-Herp-F was also inserted into pcDNA 3.1
(Invitrogen) at EcoRI and SalI sites (designated pcDNA-vUb-Herp-
Fig. 1. Schematic representation of Herp lacking the ULD (vUb-Herp) (A) and the cellular localization of vUb-Herp (B). A: vUb-Herp en-
codes Herp that lacks the residues Val10^Cys86. The gray box illustrates the ULD. B: HeLa cells were transiently transfected with pCI-Herp-F
or pCI-vUb-Herp-F. The cells were immunostained with anti-FLAG antibody. Scale bar, 10 Wm.
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F). The Bsu36I-SalI fragment of vUb-Herp-F cDNA was replaced
with that of wild-type Herp and inserted at the EcoRI and SalI sites
of pMX, producing pMX-vUb-Herp. The retrovirus-mediated infec-
tion was carried out as previously reported [11].
2.3. Fluorescent immunocytochemistry
HeLa cells were grown in Dulbecco’s modi¢ed Eagle’s medium
(Invitrogen) supplemented with 10% fetal bovine serum on 35-mm
dishes. The cells were transfected with pCI-Herp-F or pCI-vUb-
Herp-F using FuGENE6 (Roche). At 24 h post transfection, the cells
were immunostained with anti-FLAG rabbit polyclonal antibody (Sig-
ma) followed by Alexa Fluor 488-labeled secondary antibody (Molec-
ular Probes) as previously described [13]. Fluorescence was visualized
with the Axiovert 200 microscope equipped with AxioCam (Carl
Zeiss).
2.4. Immunoprecipitation, immunoblotting and sandwich ELISA
Cultured cells were lysed in RIPA bu¡er (150 mM NaCl, 10 mM
Tris^HCl pH 7.5, 1% Nonidet P-40, 0.1% sodium dodecyl sulfate
(SDS) and 0.2% sodium deoxycholate) containing a protease inhibitor
cocktail. The solubilized proteins were subjected to immunoprecipita-
tion as previously described [24]. The precipitated proteins were re-
solved by SDS^polyacrylamide gel electrophoresis on 4^20% gel for
the detection of PS and Herp, and on 7.5% gel for the detection of
intracellular APP. Immunoblotting was performed as previously re-
ported [24]. Enzyme-linked immunosorbent assay (ELISA) for AL
was performed as previously described [22]. The capture antibody
used was BNT77. Detector antibodies were horseradish peroxidase
(HRP)-conjugated BA27 (for AL40) and HRP-conjugated BC05 (for
AL42). ELISA data were statistically analyzed by ANOVA using Stat-
View-J.4.11.
2.5. Cycloheximide and lactacystin treatment
Cells (5U105) plated on 60-mm tissue culture dishes were grown for
24 h, then cycloheximide and/or lactacystin were added to ¢nal con-
centrations of 30 Wg/ml and 100 WM, respectively. At various times
after the addition of cycloheximide and/or lactacystin, the cells were
harvested and then lysed in RIPA bu¡er.
3. Results and discussion
As previously reported, Herp has the N-terminal region,
Val14^Val85, which includes the stretch sharing 32% identity
with the Val5^Val70 stretch of ubiquitin [13]. In order to elu-
cidate the role for this ULD of Herp, we generated Herp
lacking the residues Val10^Cys86 (designated vUb-Herp)
(Fig. 1A). We con¢rmed with the immunostaining study
that there is no signi¢cant di¡erence in intracellular localiza-
tion between Herp and vUb-Herp (Fig. 1B). Previously we
demonstrated that a high expression level of Herp enhances
PS-mediated AL generation. Therefore, in this study, we ¢rst
investigated whether the expression of vUb-Herp also in-
creases AL generation to determine whether the ULD is nec-
essary for the increase in AL generation caused by a high
expression level of Herp. As shown in Fig. 2A, vUb-Herp
expression also increased the level of AL. Thus, we concluded
that the ULD of Herp is not necessary for the enhancement of
AL generation. It was noted in our previous study that Herp
Fig. 2. E¡ect of the deletion of the ULD of Herp on AL generation. A: Murine ¢broblasts (2U105) expressing APP695 were retrovirally trans-
fected with pMX (mock), pMX-Herp or pMX-vUb-Herp. AL secreted during a 72-h culture was detected by ELISA. Values are meansRS.D.
of four independent dishes (n=4). Similar results were obtained from four independent experiments. Relative amounts of AL (¢gures in paren-
theses) were determined by calculating the ratio of the amounts of AL secreted from the cells expressing Herp or vUb-Herp to the mean
amount of AL secreted by a mock transfectant (normalized to 1). For AL40, *P6 0.01; **P6 0.01; ***P6 0.01 (Mann^Whitney U-test). For
AL42, *P6 0.05; **P6 0.01; ***P6 0.05. B: Lysates (10 Wg) were immunoblotted with the anti-Herp antibody (upper panel). Intracellular
APP level (holo APP) was detected with the anti-C-terminal APP antibody, 369 (lower panel). WB, Western blots.
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induced a greater increase in AL40 level than AL42 level in
HEK293 cells [12], but in ¢broblasts the extents of increase in
both AL40 and AL42 levels were almost the same (Fig. 2A).
The e¡ect of Herp on AL42 generation appears to be di¡erent
between the two cell types. It was also noted that, as shown in
Fig. 2A, the extent of increase induced by the expression of
vUb-Herp was slightly higher than that induced by the ex-
pression of wild-type Herp, probably because the protein level
of vUb-Herp was higher than that of Herp (Fig. 2B; see
below: the ULD is involved in Herp degradation). We next
determined whether vUb-Herp can also bind to PS, since
Herp interacts with the full-length PS as previously reported
[12]. As shown in Fig. 3, vUb-Herp bound to the full-length
PS1, but failed to bind to PS1 NTF. We also noted that vUb-
Herp bound to the full-length PS2 (data not shown). Taken
together, these data show that the ULD of Herp is not in-
volved in the pathway leading to the enhancement of AL
generation and in the interaction with PS.
We next examined the e¡ect of the deletion of the ULD of
Herp on intracellular Herp stability, because it is well estab-
lished that ubiquitin is involved in the protein degradation via
the ubiquitin/proteasome pathway. Western blot analysis of
intracellular degradation of Herp and vUb-Herp in ¢broblasts
following cycloheximide treatment revealed that Herp is rap-
idly degraded within 6 h, while vUb-Herp remains stable (Fig.
4A). The quanti¢cation of band intensity showed that the
half-life of Herp is approximately 2.5 h, while that of vUb-
Herp is more than 24 h (Fig. 4B). Furthermore, (i) Herp deg-
radation was completely inhibited after treating the cells with
the proteasome inhibitor lactacystin (Fig. 5A); (ii) the immu-
noprecipitated Herp and vUb-Herp contained smear bands
on the gel, which were immunoreactive with the anti-polyubi-
quitin antibody (Fig. 5B), strongly suggesting that Herp and
Fig. 3. Interaction between PS and Herp lacking the ubiquitin-like
domain. A: HEK293 cells stably expressing APP and PS1 transi-
ently transfected with pcDNA (mock), pcDNA-Herp-F or pcDNA-
vUb-Herp-F. RIPA-solubilized lysates (100 Wg) were immunopreci-
pitated with the anti-PS1 NTF antibody and immunoblotted with
the anti-FLAG antibody (left, three lanes). The lysates (10 Wg) were
also immunoblotted with the anti-FLAG antibody (right, three
lanes). IP, Immunoprecipitation; WB, Western blots. Herp-F, C-ter-
minally FLAG-tagged Herp; vUb-Herp-F, C-terminally FLAG-
tagged vUb-Herp. The asterisk indicates a non-speci¢c band. B: The
same RIPA-solubilized lysates (100 Wg) were immunoprecipitated
with the anti-FLAG antibody and immunoblotted with the anti-PS1
NTF antibody (left, three lanes). The lysates (10 Wg) were also im-
munoblotted with the anti-NTF antibody (right, three lanes). Note:
The anti-FLAG antibody was used for the immunoprecipitation of
Herp-F and vUb-Herp-F since the anti-Herp antibody used in this
study cannot immunoprecipitate vUb-Herp.
Fig. 4. Stabilization of Herp by deletion of the ULD. A: Wild-type
¢broblasts retrovirally expressing Herp and vUb-Herp were treated
with 30 Wg/ml cycloheximide and then harvested at the times indi-
cated. Herp or vUb-Herp in the RIPA-solubilized lysates (10 Wg)
was detected by immunoblotting with the anti-Herp antibody. As a
control for the stable protein in the lysates, L-tubulin was immuno-
detected with anti-L-tubulin antibody. Upper panel: lysates from
cells expressing Herp; lower panel: lysates from cells expressing
vUb-Herp. The blots are representative of four independent experi-
ments. B: The intensities of the bands corresponding to Herp, vUb-
Herp and L-tubulin in A were quanti¢ed densitometrically using
NIH Image software (PDI). Relative intensity was calculated as per-
centage of the intensity at time 0. Time, the time period of cyclo-
heximide treatment.
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vUb-Herp undergo polyubiquitination. Taken together, Herp
is degraded most likely via the ubiquitin/proteasome pathway,
and the ULD is not involved in Herp polyubiquitination.
In this study, we noted that the ULD of Herp is not essen-
tial for the increase in AL generation mediated by Herp ex-
pression. We also demonstrated that the ULD of Herp is in-
deed involved in the degradation of Herp, most likely via the
ubiquitin/proteasome pathway. Recently, it has been shown
that the ULD of parkin regulates the intracellular parkin level
and parkin polyubiquitination does not require the ULD [21].
In this regard, the ULD of Herp has a role very similar to
that of parkin. However, it is not known how the ULD of
Herp is involved in Herp degradation. Further study of the
role of the ULD in Herp degradation is necessary. At present,
the function of this protein is not known; Herp may, how-
ever, mediate the degradation of misfolded proteins induced
by ER stress through the ULD, since Herp is the ER-stress-
inducible ER-resident protein. The ER-associated degradation
(ERAD) pathway is known to direct the ubiquitin-mediated
degradation of various ER-associated misfolded proteins (re-
viewed in [25]). In response to ER stress, a series of ERAD-
related genes are induced [26,27]. Parkin is also suggested to
be involved in ERAD (reviewed in [28]). Therefore, Herp may
also be an ERAD-related gene.
Since a strong ubiquitin immunoreactivity is associated with
the pathogenesis of AD [29], the ubiquitin/proteasome protein
degradation system appeared to be impaired in the brains of
AD patients. We demonstrated that a high expression level of
Herp enhanced AL generation, and Herp is degraded via the
ubiquitin/proteasome pathway. Therefore, an impairment of
the ubiquitin/proteasome system in AD may reduce Herp deg-
radation, resulting in the enhancement of AL generation in-
duced by a higher level of Herp.
Taking these data together, the ULD of Herp most likely
plays a role in the regulation of the intracellular level of Herp
under ER stress, and also possibly in AD pathogenesis. Fur-
ther study of the mechanism underlying Herp degradation and
the Herp-mediated increase in AL generation is required.
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